Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Retinoid X receptor-gamma agonists and retinoid X receptor-alpha antagonists for treatment of cancer

Retinoid X receptor-gamma agonists and retinoid X receptor-alpha antagonists for treatment of cancer

US Patent 10286000 · Granted May 14, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CLL-1 targeted immunotherapies2025
Dimerizing agent regulated immunoreceptor complexes2025
Salvage chimeric antigen receptor systems2024
Method for NK cell transduction2024
Dimerizing agent regulated immunoreceptor complexes comprising interleukin recep2024
Chimeric antigen receptor specific for BDCA2 antigen2023
Anti-CD7 chimeric antigen receptor and method of use thereof2022
Method of forming a negative ion emitting product and a product formed by such m2019